Susan Bernstein is a freelance journalist based in Atlanta.
You Might Also Like
Explore This IssueMarch 2018
Also By This Author
- Chang HK, Al-Kindi SG, Jandali B, et al. Incidence and risk of heart failure in systemic lupus erythematosus. Heart. 2017;103(3):227–233.
- Schoenfeld SR, Kasturi S, Costenbader KH. The epidemiology of atherosclerotic cardiovascular disease among patients with SLE: A systematic review. Semin Arthritis Rheum. 2013 Aug;43(1):77–95.
- Urowitz MB, Gladman DD, Anderson MM, et al. Cardiovascular events prior to or early after diagnosis of systemic lupus erythematosus in the systemic lupus international collaborating clinics cohort. Lupus Sci Med. 2016 Apr;3(1):e000143.
- Recio-Mayoral A, Mason JC, Kaski JC, et al. Chronic inflammation and coronary microvascular dysfunction in patients without risk factors for coronary artery disease. Euro Heart Jour. 2009;30:1837–1843.
- Calabrese F, Thiene G. Myocarditis and inflammatory cardiomyopathy: Microbiological and molecular biological aspects. Cardiovasc Res. 2003;60:11–25.
- Tselios K, Gladman DD, Harvey P, et al. Prolonged antimalarial treatment increases the risk for severe brady-arrhythmias in systemic lupus erythematosus [abstract 1590]. Arthritis Rheumatol. 2017;69(suppl 10).
- Gormezano NW, Kern D, Pereira OL, et al. Autoimmune hemolytic anemia in systemic lupus erythematosus at diagnosis: Differences between pediatric and adult patients. Lupus. 2017 Apr;26(4):426-430.
- Provan D, Stasi R, Newland AC, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010; 115: 168–186.
- McMillan R, Wang L, Tomer A, et al. Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP. Blood. 2004, 103:1364–1369.